Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel and Minimal Invasive Biomarkers for Parkinson's Disease: Profiling of Serum Circulating miRNAs and Patho-physiological Implications

NCT03466723 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.

NCT NCT03466723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03466723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel and Minimal Invasive Biomarkers for Parkinson's Disease: Profiling of Serum Circulating miRNAs and Patho-physiological Implications
Lead sponsor
Neuromed IRCCS
Phase
Observational
Overall status
Completed
Start date
February 14, 2019
Completion date
June 14, 2022
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease